Testing for bladder cancer in women typically starts with a urine test and, depending on your risk level, progresses through imaging, a visual exam of the bladder, and possibly a tissue biopsy. The process can involve several steps because no single test catches every case. Women face a unique challenge: bladder cancer symptoms like blood in urine and urinary urgency overlap heavily with urinary tract infections and menstrual changes, which can delay the correct diagnosis. Understanding what each test does and when it’s needed can help you advocate for a thorough workup.
Urine Tests: The Starting Point
The first step is almost always a urinalysis, a simple lab test that checks your urine for blood, infection, and abnormal cells. Even if you can’t see blood when you urinate, a urinalysis can detect microscopic amounts of blood (called microhematuria) that aren’t visible to the naked eye. If blood is found, your doctor will want to rule out common causes like a UTI or kidney stones before moving toward cancer-specific testing.
A more specialized urine test called urine cytology examines your sample under a microscope for cancer cells. Cytology is better at catching aggressive, fast-growing tumors than slow-growing ones. Its detection rate ranges from about 50 to 85 percent for high-grade cancers but drops to just 10 to 44 percent for low-grade tumors. That gap is why cytology is used alongside other tests rather than on its own. A negative cytology result does not rule out bladder cancer.
How Doctors Assess Your Risk Level
If microhematuria is confirmed, current guidelines from the American Urological Association call for sorting patients into risk categories: low, intermediate, or high risk for a urinary tract malignancy. Your category determines how aggressively your doctor investigates.
The 2025 guidelines specifically account for the fact that women have a lower overall risk of bladder cancer than men. Women under 60 with no other risk factors now fall into the low-risk group, a change from the previous cutoff of 50. Women 60 and older are placed in the intermediate-risk group based on age, but importantly, women should not be classified as high-risk based on age alone. High-risk classification for women requires at least one additional factor, such as a history of smoking, visible blood in the urine, prior pelvic radiation, or occupational exposure to certain industrial chemicals.
If your initial urine test shows blood but you’re categorized as low risk, your doctor may simply repeat the urinalysis in a few months. If the blood persists on repeat testing, you’ll be reclassified as intermediate or high risk, and more thorough testing follows.
Imaging: CT Urogram and Ultrasound
For women in the intermediate or high-risk category, imaging helps doctors look at the bladder and the upper urinary tract (the kidneys and the tubes connecting them to the bladder). A CT urogram is the most common imaging choice. It’s a specialized CT scan where contrast dye is injected into a vein, then scanned as it filters through your kidneys and into your bladder. This gives a detailed picture of the entire urinary system and can reveal tumors, blockages, or structural abnormalities.
Ultrasound is sometimes used as an alternative, particularly when radiation exposure is a concern or CT isn’t available. It can detect tumors within the bladder itself but is less reliable for imaging the upper tract. For most women at elevated risk, a CT urogram provides a more complete evaluation.
Cystoscopy: A Direct Look Inside the Bladder
Cystoscopy is the most important diagnostic test for bladder cancer. It lets a urologist look directly at the inner lining of your bladder using a thin tube with a camera on the end, called a cystoscope, which is inserted through the urethra.
There are two types. A flexible cystoscope bends to follow the natural curve of your urethra, making the procedure more comfortable. It’s typically done in an office setting with a local numbing gel and takes only a few minutes. You’re awake the entire time. A rigid cystoscope doesn’t bend and is used when the doctor needs to pass instruments through it, for instance to take a tissue sample. Rigid cystoscopy usually requires sedation or general anesthesia.
For women, the procedure tends to be quicker and less uncomfortable than for men because the female urethra is significantly shorter. You may feel pressure or a brief stinging sensation, and mild burning during urination for a day or two afterward is normal. Most women return to regular activities the same day.
Why Bladder Cancer Is Often Missed in Women
The most common symptom of bladder cancer is blood in the urine, but in women, this is frequently attributed to menstruation, menopause-related changes, or recurrent UTIs. A woman who visits her doctor with urinary frequency, urgency, and traces of blood may receive multiple rounds of antibiotics before anyone considers a bladder-specific evaluation. This pattern of misattribution can delay diagnosis by months.
If you’ve been treated for repeated UTIs but your symptoms keep coming back, or if urine cultures aren’t actually growing bacteria despite your symptoms, it’s reasonable to ask about cystoscopy. Persistent or unexplained hematuria in a woman over 60, especially one with a smoking history, warrants investigation beyond a standard UTI workup.
Biopsy and Tumor Removal (TURBT)
If cystoscopy reveals a suspicious growth, the next step is a procedure called transurethral resection of a bladder tumor, or TURBT. This serves as both a diagnostic biopsy and the initial treatment. During TURBT, the urologist passes a cystoscope through your urethra into the bladder and uses a small cutting tool to remove the tumor from the bladder wall. No incisions are made on the outside of your body.
The removed tissue goes to a pathology lab, where a specialist examines it to determine two critical things: the stage (how deep the tumor has grown into the bladder wall) and the grade (how abnormal the cells look compared to healthy tissue). These results shape every treatment decision that follows. A tumor confined to the bladder’s inner lining is treated very differently from one that has invaded the muscle layer beneath it.
TURBT is done under general or spinal anesthesia, and most patients go home the same day or the next morning. You may notice blood in your urine for a week or two afterward, and your doctor will likely schedule a follow-up cystoscopy within a few months to check for recurrence, since bladder tumors have a tendency to come back.
What the Full Testing Sequence Looks Like
Putting it all together, the typical path from first symptom to diagnosis looks like this:
- Urinalysis: Detects blood or abnormal cells in urine.
- Risk stratification: Your age, smoking history, and other factors determine how urgently you need further testing.
- Urine cytology: Checks for cancer cells shed into the urine, most useful for catching high-grade tumors.
- Imaging (CT urogram or ultrasound): Scans the kidneys, ureters, and bladder for visible masses.
- Cystoscopy: Provides a direct visual inspection of the bladder lining.
- TURBT: Removes and biopsies any suspicious tissue for definitive diagnosis and staging.
Not every woman will need every step. Someone in the low-risk category with a single episode of microscopic blood may only need repeat urinalysis and monitoring. Someone with visible blood in the urine, a long smoking history, and persistent symptoms will likely move quickly through imaging, cystoscopy, and potentially TURBT. The key is making sure that symptoms aren’t dismissed as routine, particularly when they persist after initial treatment for other conditions.